Keyword Analysis & Research: pharmacyclics
Keyword Research: People who searched pharmacyclics also searched
Search Results related to pharmacyclics on Search Engine
-
Pharmacyclics
https://www.pharmacyclics.com/
WebPharmacyclics is an AbbVie company based in the Bay Area, California. Our charge is to help people impacted by cancer and immune-mediated diseases by focusing on the development of safe and effective treatment options. We will know that our mission has been achieved when patients and their families have rediscovered the Magic of Normal ...
DA: 23 PA: 73 MOZ Rank: 17
-
Pharmacyclics - Wikipedia
https://en.wikipedia.org/wiki/Pharmacyclics
WebPharmacyclics LLC is an American biopharmaceutical company based in Sunnyvale, California. It is primarily focused on the development of cancer therapies. In 2017, Xynomic Pharmaceuticals acquired all global rights to Abexinostat, Pharmacyclics' primary commercial product. Acquisition by AbbVie
DA: 57 PA: 20 MOZ Rank: 39
-
AbbVie to Acquire Pharmacyclics, including its blockbuster …
https://investors.abbvie.com/news-releases/news-release-details/abbvie-acquire-pharmacyclics-including-its-blockbuster-product
WebMar 4, 2015 · Pharmacyclics, Inc. (NASDAQ: PCYC) is a biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. The company's mission is to build a viable biopharmaceutical company that designs, develops and commercializes novel …
DA: 6 PA: 54 MOZ Rank: 59
-
Areas of Study - Pharmacyclics
https://www.pharmacyclics.com/home/areas-of-study.html
WebPhase 3. Ibrutinib w/ Venetoclax vs. Chlorambucil w/ Obinutuzumab. Chronic Lymphocytic Leukemia/. Small Lymphocytic Lymphoma. (CLL/SLL) First Line Treatment. Young/Fit Patients. Phase 2. Venetoclax +/- Ibrutinib.
DA: 78 PA: 8 MOZ Rank: 60
-
Pharmacyclics’ ‘miracle cure’: A cancer drug saves a biotech …
https://www.seattletimes.com/business/technology/pharmacyclics-miracle-cure-a-cancer-drug-saves-a-biotech-company/
WebJan 9, 2016 · SUNNYVALE, Calif. — Biotech company Pharmacyclics was teetering toward bankruptcy. Its one big product had flopped. Its top chemist, co-founders and entire board resigned, frustrated and ...
DA: 91 PA: 72 MOZ Rank: 96
-
Pharmacyclics, an AbbVie Company | LinkedIn
https://www.linkedin.com/company/pharmacyclics
WebPharmacyclics, an AbbVie Company | 28,135 followers on LinkedIn. Striving to bring back the magical of normal. | Pharmacyclics is committed to the development and commercialization of novel ...
DA: 6 PA: 40 MOZ Rank: 46
-
News Center | AbbVie News Center
https://news.abbvie.com/news/abbvie-to-acquire-pharmacyclics-including-its-blockbuster-product-imbruvica-creating-an-industry-leading-hematological-oncology-franchise.htm
WebAbbVie, a global biopharmaceutical company, announced its plan to buy Pharmacyclics, the maker of Imbruvica, a breakthrough drug for blood cancers. Learn more about this deal and how it will enhance AbbVie's leadership in hematological oncology.
DA: 89 PA: 54 MOZ Rank: 48
-
Healthcare Professionals - pharmacyclics.com
https://www.pharmacyclics.com/home/healthcare-professionals.html
WebWe are here to partner with you and make a difference. As your partner in care, we are here to collaborate with you to help make positive differences in the health and well-being of patients. Together, we can work to provide transformative therapies for patients with unmet medical need. Below are resources that may be helpful for you or your ...
DA: 99 PA: 84 MOZ Rank: 42
-
News Center | AbbVie News Center
https://news.abbvie.com/news/abbvie-completes-acquisition-pharmacyclics.htm
WebNews Center | AbbVie News Center
DA: 63 PA: 80 MOZ Rank: 93
-
AbbVie to Acquire Pharmacyclics, including its blockbuster …
https://www.fiercepharma.com/pharma/abbvie-to-acquire-pharmacyclics-including-its-blockbuster-product-imbruvica%C2%AE-creating-an
WebMar 4, 2015 · Pharmacyclics, Inc. (NASDAQ: PCYC) is a biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.
DA: 12 PA: 32 MOZ Rank: 44